Allscripts (MDRX) volatility flat into investor day
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/21/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- Tesla acquires AI hardware company for up to $2 billion in stock
- Bel Fuse acquires dataMate ethernet business for $16 million
- Fed: Nine Of 18 FOMC Participants Pencil In 2026 Rate Hike
Cantor Fitzgerald Remains Sidelined on Allscripts (MDRX) Following Analyst Meeting
March 22, 2017 7:34 AM EDTCantor Fitzgerald reiterated a Neutral rating and $13.00 price target on Allscripts (NASDAQ: MDRX) following an analyst meeting. The company indicated that its customer satisfaction scores among US acute care hospitals improved by 16% in 2016 vs. 2015 levels. MDRX is also leveraging its investments in dbMotion... More
Jefferies Reiterates Buy on Allscripts (MDRX) Following Investor Day
March 22, 2017 7:01 AM EDTJefferies reiterated a Buy rating and $16.50 price target on Allscripts (NASDAQ: MDRX) following the company's investor day.
Analyst Sean Dodge commented, "MDRX is firmly on a path toward more sustainable revenue growth which when coupled with its lean cost structure should... More
